XFOR

XFOR

USD

X4 Pharmaceuticals Inc. Common Stock

$3.970-0.030 (-0.750%)

Preço em tempo real

Healthcare
Biotecnologia
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$4.000

Máximo

$4.120

Mínimo

$3.940

Volume

0.20M

Fundamentos da empresa

Capitalização de mercado

314.5M

Setor

Biotecnologia

País

United States

Estatísticas de negociação

Volume médio

4.09M

Bolsa de valores

NCM

Moeda

USD

Faixa de 52 semanas

Mínimo $1.35Atual $3.970Máximo $26.82

Notícias relacionadas

Analyst Upgrades

HC Wainwright & Co. Maintains Buy on X4 Pharmaceuticals, Raises Price Target to $5

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains X4 Pharmaceuticals with a Buy and raises the price target from $3.5 to $5.

Ver mais
HC Wainwright & Co. Maintains Buy on X4 Pharmaceuticals, Raises Price Target to $5
GlobeNewswire

X4 Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $155.3 Million

BOSTON, Oct. 27, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (NASDAQ:XFOR) ("X4" or the "Company"), a company driven to improve the lives of people with rare hematology diseases, today announced the closing of its

Ver mais
X4 Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $155.3 Million
GlobeNewswire

X4 Pharmaceuticals Announces Pricing of $135 Million Underwritten Public Offering

BOSTON, Oct. 24, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (NASDAQ:XFOR) ("X4" or the "Company"), a company driven to improve the lives of people with rare hematology diseases, today announced the pricing of its

Ver mais
X4 Pharmaceuticals Announces Pricing of $135 Million Underwritten Public Offering

Mantenha-se atualizado

Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.